药物开发管理理学硕士

药物开发管理（MSD）中的MS将化学进化，质量体系的实施以及对动物和人类的检测结合在一起。在此程序中，您将学习管理此复杂路径的各个方面。您和您的同伴将具备处理良好的实验室和临床过程的能力，并从项目管理的角度促进药物开发，从而使您能够以更加面向团队的方式应对科学方面的智力挑战。<br>这个新颖的学位该计划是为具有临床前生物学和药学背景的学生设计的。它旨在培养入门级和中级从业人员，使他们具备适用于转化研究专业实践的知识和技能，并特别强调早期临床前药物发现与临床药物开发之间的过渡领域。该计划解决了当前教育计划中
A Master of Science degree in the management of drug development will be granted upon completion of at least 32 units of course work. The program is offered on both a full-time and part-time basis, and courses are also available in distance formats. Course requirements normally include a minimum of three courses concerned with translational aspects of medical product development. Recommended courses to satisfy this core requirement include RSCI 531, RSCI 532, PSCI 664 or CXPT 609. The program must also include a minimum of one course in each of: regulatory science, quality assurance, clinical research, business and statistics. Students should develop a specific plan of study in consultation with graduate advisers before beginning the program.